Autopsy report · NCT04002011
DOAC Versus VKA After Cardiac Surgery
Cause of deathSlow enrollment
“Submission process abandoned. No patient enrolled.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Laval University
- Sponsor type
- University, hospital or other
- Conditions
- Anticoagulant-induced Bleeding
- Interventions
- Warfarin; Dabigatran; Rivaroxaban; Apixaban; Edoxaban
- Participants
- 0
Trials that died the same way
- Effects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary Disease
“no patient enrolled.” - Efficacy of rTMS (Repetitive Transcranial Magnetic Stimulation) on Patients With Somatoform Pain Disorder
“patient did not enroll” - A2R and Ectonucleotidases Expression in Lung Cancer Circulating Tumor Cells
“no patients enrolled” - Pharmacokinetic Assessment of Ceftazidime in Intermittent Hemodialysis Patients
“did not enroll a patient” - Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic Infertility
“No further patient enrollment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.